HUP0103708A2 - Gombaellenes hatással rendelkező vegyületeket tartalmazó orális gyógyszerkészítmények és eljárás előállításukra - Google Patents

Gombaellenes hatással rendelkező vegyületeket tartalmazó orális gyógyszerkészítmények és eljárás előállításukra

Info

Publication number
HUP0103708A2
HUP0103708A2 HU0103708A HUP0103708A HUP0103708A2 HU P0103708 A2 HUP0103708 A2 HU P0103708A2 HU 0103708 A HU0103708 A HU 0103708A HU P0103708 A HUP0103708 A HU P0103708A HU P0103708 A2 HUP0103708 A2 HU P0103708A2
Authority
HU
Hungary
Prior art keywords
preparation
compound
pharmaceutical oral
antifungic
activity
Prior art date
Application number
HU0103708A
Other languages
English (en)
Inventor
Carlos Picornell Darder
Original Assignee
Liconsa, Liberación Controlada de Sustancias Activas, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0103708(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa, Liberación Controlada de Sustancias Activas, S.A. filed Critical Liconsa, Liberación Controlada de Sustancias Activas, S.A.
Publication of HUP0103708A2 publication Critical patent/HUP0103708A2/hu
Publication of HUP0103708A3 publication Critical patent/HUP0103708A3/hu
Publication of HU228895B1 publication Critical patent/HU228895B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
HU0103708A 1998-07-21 1999-07-20 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method HU228895B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (3)

Publication Number Publication Date
HUP0103708A2 true HUP0103708A2 (hu) 2002-02-28
HUP0103708A3 HUP0103708A3 (en) 2002-07-29
HU228895B1 HU228895B1 (en) 2013-06-28

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103708A HU228895B1 (en) 1998-07-21 1999-07-20 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method

Country Status (31)

Country Link
US (1) US6737082B1 (hu)
EP (1) EP1103252B1 (hu)
JP (1) JP4190732B2 (hu)
KR (1) KR100572135B1 (hu)
AT (1) ATE234077T1 (hu)
AU (1) AU750730B2 (hu)
BG (1) BG65187B1 (hu)
BR (1) BR9912300A (hu)
CA (1) CA2337509C (hu)
CZ (1) CZ291938B6 (hu)
DE (1) DE69905905T2 (hu)
DK (1) DK1103252T3 (hu)
EE (1) EE04415B1 (hu)
ES (2) ES2157731B1 (hu)
HK (1) HK1037531A1 (hu)
HR (1) HRP20010128B1 (hu)
HU (1) HU228895B1 (hu)
IL (1) IL140910A (hu)
ME (1) MEP26708A (hu)
MX (1) MXPA01000681A (hu)
NO (1) NO320054B1 (hu)
NZ (1) NZ509886A (hu)
PL (1) PL194740B1 (hu)
PT (1) PT1103252E (hu)
RS (1) RS50063B (hu)
RU (1) RU2209628C2 (hu)
SK (1) SK283279B6 (hu)
TR (1) TR200100177T2 (hu)
UA (1) UA64009C2 (hu)
WO (1) WO2000004881A1 (hu)
ZA (1) ZA200101293B (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1122456C (zh) * 1996-01-31 2003-10-01 南亚拉巴马医学科学基金会 含有天然的还原叶酸盐异构体的食品和维生素制品
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1402629A (zh) 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
SI1438961T2 (sl) * 2003-01-14 2014-12-31 Cimex Pharma Ag Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
BRPI0412734A (pt) * 2003-07-17 2006-09-26 Tibotec Pharm Ltd processo para preparação de partìculas que contêm um antiviral
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
JP5435946B2 (ja) 2005-08-22 2014-03-05 ジョンズ ホプキンス ユニバーシティ 疾患を処置するためのヘッジホッグ経路アンタゴニスト
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2542222A2 (de) * 2010-03-05 2013-01-09 Basf Se Schmelzüberzogene arzneiformen
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
RU2017141029A (ru) * 2015-05-25 2019-06-25 Сан Фармасьютикал Индастриз Лимитед Фармацевтическая пероральная композиция изотретиноина для применения один раз в сутки
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
WO2019208801A1 (ja) * 2018-04-27 2019-10-31 凸版印刷株式会社 徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
IL124935A (en) * 1996-05-20 2001-06-14 Janssen Pharmaceutica Nv Dissolvable fungicidal preparations contain itraconazole with improved bioavailability
PE68898A1 (es) * 1996-05-24 1998-11-10 Schering Corp Composiciones antihongo con biodisponibilidad mejorada
KR20000022294A (ko) * 1996-06-28 2000-04-25 둘락 노먼 씨. 트리아졸 항진균 화합물을 함유하는 경구 조성물
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
PT969821E (pt) * 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero

Also Published As

Publication number Publication date
ES2194480T3 (es) 2003-11-16
YU3901A (sh) 2003-08-29
NZ509886A (en) 2002-09-27
HUP0103708A3 (en) 2002-07-29
JP2002521323A (ja) 2002-07-16
KR20010070990A (ko) 2001-07-28
NO320054B1 (no) 2005-10-17
BG65187B1 (bg) 2007-06-29
ATE234077T1 (de) 2003-03-15
ZA200101293B (en) 2001-08-21
HRP20010128B1 (en) 2003-12-31
PL194740B1 (pl) 2007-06-29
CA2337509A1 (en) 2000-02-03
NO20010289L (no) 2001-03-07
US6737082B1 (en) 2004-05-18
EP1103252B1 (en) 2003-03-12
ES2157731B1 (es) 2002-05-01
IL140910A (en) 2004-03-28
EE200100041A (et) 2002-06-17
PT1103252E (pt) 2003-07-31
DK1103252T3 (da) 2003-07-14
HRP20010128A2 (en) 2002-12-31
DE69905905D1 (de) 2003-04-17
BG105282A (en) 2001-11-30
RU2209628C2 (ru) 2003-08-10
DE69905905T2 (de) 2004-03-04
KR100572135B1 (ko) 2006-04-19
TR200100177T2 (tr) 2001-07-23
NO20010289D0 (no) 2001-01-17
AU4782199A (en) 2000-02-14
ES2157731A1 (es) 2001-08-16
SK283279B6 (sk) 2003-05-02
IL140910A0 (en) 2002-02-10
CZ291938B6 (cs) 2003-06-18
MEP26708A (en) 2010-06-10
MXPA01000681A (es) 2002-04-24
AU750730B2 (en) 2002-07-25
HK1037531A1 (en) 2002-02-15
EP1103252A1 (en) 2001-05-30
PL345625A1 (en) 2002-01-02
UA64009C2 (en) 2004-02-16
EE04415B1 (et) 2005-02-15
CZ2001175A3 (en) 2001-05-16
WO2000004881A1 (es) 2000-02-03
SK862001A3 (en) 2001-08-06
JP4190732B2 (ja) 2008-12-03
BR9912300A (pt) 2001-04-17
RS50063B (sr) 2009-01-22
HU228895B1 (en) 2013-06-28
CA2337509C (en) 2005-12-27

Similar Documents

Publication Publication Date Title
HUP0103708A3 (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
ZA986893B (en) Oral pharmaceutical preparation which includes a compound of anti-ulcer activity and procedure for making same
AP2000001757A0 (en) Solid oral dosage form comprising a combination of metforming and glibenclamide
PL304060A1 (en) Solid dosed form of prolonged release for oral administration and method of obtaining same,
GB9927202D0 (en) A method of microencapsulation
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
AU1998200A (en) Multiparticulate oral dosage forms
EP1020193A4 (en) ORAL PREPARATION
AU7375598A (en) Stable oral pharmaceutical dosage forms
HUP0100347A3 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation
GB2359748B (en) True ibuprofen solution, an ibuprofen dosage form and a method of making an ibuprofen dosage form
PL342345A1 (en) Active substance suspension for oral administration
PL331507A1 (en) Method of obtaining a pharmaceutic agent, pharmaceutic agent obtained thereby and pharmaceutical kit for application thereof
AU4143999A (en) Oral composition comprising capsules
PL341230A1 (en) Solid dosage forms of ribavirin for oral administration and method of obtaining them
MXPA01006824A (es) Cepillo dental lingual y metodo para fabricar el mismo.
PL343600A1 (en) Catalytic composition comprising a titanium compound, an amine and a phosphorus compound; preparation and use thereof
HK1045950B (zh) 普魯卡羅酰胺口服溶液及其製備方法
ZA986320B (en) A method for the preparation of tertiary amines a compound useful therefor and alpha-2-receptor active tetrahyd-roisoquinoline derivatives
AU2150600A (en) System and method for providing a dental diagnosis
SI1103252T1 (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
HUP0103569A3 (en) New medicament and process for its preparation
ZA200106445B (en) Liposome composition and method for administration of a radiosensitizer.
AU2447097A (en) Oral coated active drugs
IL136230A0 (en) An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: LABORATORIOS LICONSA, S.A., ES

Free format text: FORMER OWNER(S): LICONSA, LIBERACION CONTROLADA DE SUSTANCIAS ACTIVAS, S.A., ES

MM4A Lapse of definitive patent protection due to non-payment of fees